slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 20,071-20,100
Pages 3,683
Rows per page 30
Component
20,071-20,100 of 110,471
64
The slide uses academic citations to undermine the novelty of the company's technology.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
103
Uses expert testimony to debunk specific technical claims made by a competitor (QS).QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Beat · Critique of Quantumscape's claims and technology3 hits
169
Uses external press citations to undermine the credibility of the target company's investors.QuantumScape (QS) · Scorpion Capital
Activist deck Short seller Loop · Cost Of Inaction3 hits
61
This slide presents expert testimony/critique from a trial investigator, serving as a 'villain_critique' or 'expose_contradiction' style slide.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
69
The slide uses direct quotes from an expert to undermine the value proposition of the subject company's product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
74
The slide uses direct quotes to undermine the credibility of the drug's approval and market demand.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
75
The slide uses direct quotes from an expert consultation to undermine the company's product launch and clinical efficacy claims.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
81
The slide captures qualitative feedback from a medical expert, highlighting low adoption rates and negative sentiment toward the company's sales approach.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
82
The slide uses direct quotes to undermine the company's marketing claims and highlight physician concerns regarding side effects like diabetes.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
83
The slide uses direct quotes from an expert to undermine the company's clinical narrative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
84
The slide uses direct quotes to undermine the company's marketing claims about drug efficacy and differentiation.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
87
The slide uses direct quotes to validate the activist's thesis regarding the drug's risks and market limitations.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
88
The slide highlights the gap between physician prescribing behavior (driven by patient pressure) and their actual clinical belief in the product.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
89
This slide presents qualitative interview data from a medical expert to undermine the credibility of a drug and a key opinion leader.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
91
The slide uses direct quotes to highlight expert skepticism regarding safety, efficacy, and pricing.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
92
The slide presents qualitative expert feedback from a medical professional regarding drug safety concerns.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
94
This slide presents qualitative feedback from a medical expert, highlighting significant barriers to adoption for the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
96
The slide presents a qualitative critique from a medical professional, highlighting skepticism regarding clinical efficacy and administrative burden.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
97
The slide uses direct quotes to undermine the clinical value and safety profile of the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
143
The slide uses a causal chain structure to explain the side effect.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
226
The slide uses direct quotes from an ex-employee to build a case of corporate misconduct regarding clinical trial data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
269
The slide uses direct quotes from an Anthem VP to undermine the product's market viability.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
347
The slide uses a combination of summary text and verbatim Q&A transcripts to highlight negative sentiment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
409
The slide uses direct quotes to build a narrative of expert doubt.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 3 hits
04
The slide uses a forensic accounting framework to explain how inventory manipulation leads to overstated earnings.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Monster3 hits
10
The slide uses strong, accusatory language to frame a technical failure as a financial fraud.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment3 hits
16
This slide functions as a 'villain critique' or 'expose' of a company's product claims.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The Struggle3 hits
21
The slide uses expert testimony to debunk the market perception of Lasertec as 'Japan's ASML'.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction3 hits
27
The slide uses investigative research to expose a gap between public PR and private sentiment regarding Lasertec's technology performance at Intel.Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction3 hits
30
The slide uses investigative reporting style to expose a negative relationship between a vendor (Lasertec) and a customer (TSMC).Lasertec Corporation (6920) · Scorpion Capital
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction3 hits